Milestone Scientific, Inc. (MLSS) Dividend History

Milestone Scientific, Inc. (MLSS) develops and manufactures innovative computer-controlled anesthesia delivery systems for dental and medical procedures. The company focuses on enhancing patient comfort and clinician precision through its advanced injection technology.

Dividend History

Milestone Scientific, Inc. currently does not pay dividends

Company News

Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors

Milestone Scientific Inc. has appointed Shanth Thiyagalingam, a seasoned MedTech executive, to its Board of Directors. Thiyagalingam brings extensive experience in commercial leadership, reimbursement strategy, and global market insights, which will support Milestone's growth across medical and dental segments.

GlobeNewswire Inc.
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon

Milestone Scientific announced the commercial rollout of its CompuFlo® Epidural System at Advanced Spine and Pain Management, following a successful pilot program. The company also reported increasing adoption of the system after a Medicare price assignment, highlighting its clinical and economic benefits.

GlobeNewswire Inc.
Milestone Scientific to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference on December 11th, 2024

Milestone Scientific Inc., a medical technology company, announced that its CEO and Chairman will be presenting at The Benchmark Company's investor conference on December 11th, 2024. The conference offers emerging growth companies access to institutional and individual investors in a one-on-one format.

GlobeNewswire Inc.
EXCLUSIVE: Milestone Scientific Announces Medicare Price Assignment For CompuFlo Epidural System For Back Pain Covering Additional US States - Benzinga

Milestone Scientific's CompuFlo Epidural System has received Medicare price assignment in additional US states, representing a significant addressable market for the company's technology.

Benzinga
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil

Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain

GlobeNewswire Inc.

Dividend data last updated 06/07/2025 19:55:57 UTC